Näytetään tulokset 1 - 10 / 104
tulosta / sivu
Mitä julkaisutietoja palvelu sisältää?
Julkaisun nimi
Tekijät
Julkaisukanava
Vuosi

Immunology and Immunotherapy of Chronic Myeloid Leukemia

Vertaisarvioitu
DOI
10.1007/s11899-013-0190-1
Ilander, Mette; Hekim, Can; Mustjoki, Satu
Current hematologic malignancy reports2014

Composition of subgingival microbiota associated with periodontitis and diagnosis of malignancy-a cross-sectional study

Vertaisarvioitu
Avoin saatavuus
DOI
10.3389/fmicb.2023.1172340
Narayanan, Aswathy; Soder, Birgitta; Meurman, Jukka; Lundmark, Anna; Hu, Yue O. O.; Neogi, Ujjwal; Y...
Frontiers in microbiology2023

Markers of malignancy in adrenocortical tumours

Avoin saatavuus
Pennanen, Mirkka
Helsingin yliopisto2020

A core needle biopsy provides more malignancy-specific results than fine-needle aspiration biopsy in thyroid nodules suspicious for malignancy.

Vertaisarvioitu
DOI
10.1136/jclinpath-2013-201559
Hakala T; Kholová I; Sand J; Saaristo R; Kellokumpu-Lehtinen P
Journal of clinical pathology2013

Risk of malignancy in resected pancreatic mucinous cystic neoplasms.

Vertaisarvioitu
DOI
10.1002/bjs.10787
Keane, M;Shamali, A;Nilsson, L;Antila, A;Millastre Bocos, J;Marijinissen Van Zanten, M;Verdejo, Gil ...
british journal surgery2018

Follicular thyroid tumours : markers of neoplasia, malignancy and prognosis

Heikkilä, Annukka
[A.Heikkilä]2013

Subsequent malignant neoplasms after primary hematological malignancy in adult patients

Vertaisarvioitu
Avoin saatavuus
DOI
10.1002/ijc.34973
Rönkkö, Rosa M.; Nevala, Aapeli O.; Pitkäniemi, Janne M.; Wartiovaara-Kautto, Ulla M.; Malila, Nea K...
International journal of cancer2024

Severe Pneumococcal Infections and Vaccination in Patients with Hematological Malignancy

Avoin saatavuus
Lindström, VesaLindström, Vesa
-2019

Nuclei Malignancy Analysis Based on an Adaptive Bottom-Hat Filter

Vertaisarvioitu
DOI
10.1007/978-3-319-53480-0_19
Ikonen, Tiia;Haataja, Keijo;Toivanen, Pekka;Tolonen, Teemu;Isola, Jorma;Heino-Tolonen, Tarja
advances intelligent systems computing2017

MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy

Vertaisarvioitu
Avoin saatavuus
DOI
10.7554/eLife.00825.001
Heinrichs, Stefan; Conover, Lillian F.; Bueso-Ramos, Carlos E.; Kilpivaara, Outi; Stevenson, Kristen...
eLife2013

Immunology and Immunotherapy of Chronic Myeloid Leukemia

Vertaisarvioitu
DOI
10.1007/s11899-013-0190-1
2014

Composition of subgingival microbiota associated with periodontitis and diagnosis of malignancy-a cross-sectional study

Vertaisarvioitu
Avoin saatavuus
DOI
10.3389/fmicb.2023.1172340
2023

Markers of malignancy in adrenocortical tumours

Avoin saatavuus
2020

A core needle biopsy provides more malignancy-specific results than fine-needle aspiration biopsy in thyroid nodules suspicious for malignancy.

Vertaisarvioitu
DOI
10.1136/jclinpath-2013-201559
2013

Risk of malignancy in resected pancreatic mucinous cystic neoplasms.

Vertaisarvioitu
DOI
10.1002/bjs.10787
2018

Follicular thyroid tumours : markers of neoplasia, malignancy and prognosis

2013

Subsequent malignant neoplasms after primary hematological malignancy in adult patients

Vertaisarvioitu
Avoin saatavuus
DOI
10.1002/ijc.34973
2024

Severe Pneumococcal Infections and Vaccination in Patients with Hematological Malignancy

Avoin saatavuus
2019

Nuclei Malignancy Analysis Based on an Adaptive Bottom-Hat Filter

Vertaisarvioitu
DOI
10.1007/978-3-319-53480-0_19
2017

MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy

Vertaisarvioitu
Avoin saatavuus
DOI
10.7554/eLife.00825.001
2013